Inexpensive drug can prevent cerebral palsy in premature babies
University of BristolGiving women at risk of premature birth a simple magnesium sulphate infusion (or ‘drip’) can prevent their babies from developing cerebral palsy, a recent Cochrane review has confirmed. The drug itself costs approximately £5 (~$6.50) per dose in England, and requires hospital admission with experienced staff to administer the drug safely to the mother. A new editorial calls for this intervention to be implemented more widely and equitably, as it is still not consistently available worldwide.